Full Text View
Tabular View
No Study Results Posted
Related Studies
Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)
Expanded access is currently available for this treatment.
Verified February 2013 by National Institute of Allergy and Infectious Diseases (NIAID)
Study NCT01309022   Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received on March 2, 2011.   Last Updated on February 7, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus, Type 1
Additional conditions recognized in this trial
Diabetes Mellitus
More general conditions related to this trial
Autoimmune Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Immune System Diseases
Metabolic Diseases
Interventions listed in this trial
Sirolimus
Tacrolimus
Mycophenolate mofetil
Mycophenolic acid
Additional drug interventions recognized in this trial
Everolimus
Immunosuppressive Agents
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antineoplastic
Antifungal Agents
Antineoplastic Agents
Enzyme Inhibitors
Immunologic Factors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
Immune Tolerance Network (ITN)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services